← Leaderboards
Kostyantyn Krysan
University Of California Los Angeles
$1,523,760
Attributed
$7,881,432
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.7M · FY2018–25$5M$3.8M$2.5M$1.3M$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,881,432 · 1
By mechanism
U01$7,881,432 · 1
Top collaborators
- Denise R Aberle8 shared
- Fang Wei8 shared
- David T Wong8 shared
- William Hsu3 shared
- Wei Liao2 shared
- Charles Martin Strom2 shared
- Xiaojing Yang1 shared
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Denise R Aberle$7,414,266
- William Hsu$2,700,990
- David Elashoff$4,613,039
- David T Wong$54,826,713
- Alex Bui$24,761,003
Others in their field
Other Emerging Leaders on “Industry Partner”
- Valerie Koch · University Corporation For Atmospheric Res$243,972,016
- John E West · University Of Texas At Austin$94,000,000
- Prasant Mohapatra · University Of California At Davis$57,204,488
- John Damon Chodera · Sloan-Kettering Inst Can Research$38,772,927
- Kathleen Maletic Neuzil · Emory University$27,466,472
- Steven Schachter · Massachusetts General Hospital$19,816,552
Research focus
Industry PartnerIndustryDetectionDiagnostic TestsElectric FieldImageCollaborationsComputed Tomography ScreeningDiagnosisDiagnosticEarly DiagnosisBlood SpecimenBlood VolumeEngineeringCancer BiologyBiological MarkersCancer DetectionCancer DiagnosisCharacteristicsClassificationBloodCirculating DnaBenignLiquid Biopsy
Grant awards (8)
EFIRM Liquid Biopsy Research Laboratory: Early Lung Cancer Assessment$2,745,735
U01 · FY2025 · CA
EFIRM Liquid Biopsy Research Laboratory: Early Lung Cancer Assessment$878,436
U01 · FY2024 · CA
EFIRM Liquid Biopsy Research Laboratory: Early Lung Cancer Assessment$932,148
U01 · FY2023 · CA
EFIRM-Liquid Biopsy (eLB): Ultrasensitive ctDNA and miRNA Detection for Early Assessment of Lung Cancer$647,157
U01 · FY2022 · CA
EFIRM-Liquid Biopsy (eLB): Ultrasensitive ctDNA and miRNA Detection for Early Assessment of Lung Cancer$670,270
U01 · FY2021 · CA
EFIRM-Liquid Biopsy (eLB): Ultrasensitive ctDNA and miRNA Detection for Early Assessment of Lung Cancer$669,593
U01 · FY2020 · CA
EFIRM-Liquid Biopsy (eLB): Ultrasensitive ctDNA and miRNA Detection for Early Assessment of Lung Cancer$652,690
U01 · FY2019 · CA
EFIRM-Liquid Biopsy (eLB): Ultrasensitive ctDNA and miRNA Detection for Early Assessment of Lung Cancer$685,403
U01 · FY2018 · CA